
Preparation and characterization of tadalafil-loaded hydrogel: An in-vivo evaluation of wound healing activity
Anita Sadat Haji Seyed Javadi Pajouhi, Amir Larki-Harcheghani, Mojdeh Mohammadi, Sajjad Makhdoomi, Alireza Nourian, Katayoun Derakhshandeh
Pharmaceutical Science Advances ›› 2025, Vol. 3 ›› Issue (0) : 100066.
Preparation and characterization of tadalafil-loaded hydrogel: An in-vivo evaluation of wound healing activity
Tadalafil (TD) is a phosphodiesterase type 5 (PDE-5) inhibitor that has gained attention for its wound healing properties. In this study, a TD-loaded hydrogel was prepared and characterized, and its wound-healing efficacy was evaluated. After preparing the TD hydrogel, its physicochemical properties such as viscosity, pH, drug-loading capacity (DL%), in vitro release behavior, and stability were characterized. Moreover, in vivo studies were performed to evaluate hydroxyproline (HP) and the wound healing efficacy of 1, 1.5, 3% (w/w) TD hydrogels in New Zealand rabbits. Histopathological analysis was also performed using hematoxylin and eosin (H&E) staining. We successfully prepared a TD hydrogel with high stability. The results of the in vivo experiments on full-thickness wounds showed that the 1.5% TD hydrogel with a pH of 5.81 ± 0.421, viscosity of 12,435 ± 63, drug-loading capacity of 91.73 ± 1.482%, and drug release rate of 88% was superior to other formulations when HP level was increased, which decreased the time required for wound healing; this was corroborated by the histological analysis. Thus, the TD hydrogel formulation prepared in this study is a promising topical therapeutic agent for wound healing.
Tadalafil / Hydrogel / Wound healing / Hydroxyproline / Phosphodiesterase type 5 inhibitor
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
/
〈 |
|
〉 |